Transpek Industry Limited · BSE:TRANSPEK

Transpek Industry — Investor Presentation (November 2020)

36 slides from Transpek Industry's investor presentation, November 2020

  1. Slide 1: Cover letter to BSE on investor presentation

    +s1 265 2335444,2335757 ,2358236 2342262,2334141 PHONE +91 265 2335758 FAX L m'lcd fi nanspeK ffiilftlffii:rY realive chemislry Vadodara - 390 007. Gujarat, (lndia) Date; 21't November, 2O2O To, BSE Limited P.J. Towers, DalalStreet, Mumbai- 400 001 Ref: Scrip Code: 506697 Subiect: lnvestor presentat

  2. Slide 2: Transpek Industry Limited Investor Presentation November 2020

    Transpek Industry Limited Investor Presentation November 2020

  3. Slide 3: Safe Harbour

    Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Transpek Industry Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any se

  4. Slide 4: Transpek at Glance

    Transpek at Glance

  5. Slide 5: About us

    About us Environment Protection Founded by Shri. Govindji Shroff in 1965 Over 5 decades Creative Over three Part of Excel experience in Chemistry decades of presence in the group of Sulphur and international companies Chlorine market Chemistry Customer Exploring every Headquartered Focus possible in

  6. Slide 6: Our journey over five decades

    Our journey over five decades 2017 Long term supply agreement with global chemical giant 2018 Started supplying under long 2004 term supply agreement and Set up of First Multi Purpose became big global player in acid Acid Chloride Plant chlorides 2012 1987 Significant strategic shift from Started ma

  7. Slide 7: Our products are supplied to varied industries

    Our products are supplied to varied industries Q2 FY21 Sales Distribution based on Application Leading global supplier for ‘Chlorinated Products’ to various industry sectors ranging from Pharmaceuticals, Agrochemicals and dyes to pigments. 6.34% 4.45% Polymers Pharma Specialty Chemicals 19.0% 70.21%

  8. Slide 8: Our products have multiple applications

    Our products have multiple applications Diversified Products Across India’s Fastest Growing Industries • 2, 4, 6 Trimethyl Benzoyl • 2-Methoxyethyl chloride • 2-Chloroethylamine • 2-Chloroethylamine Chloride • Cocoyl Chloride • 2-Propoxyethyl chloride Hydrochloride Solution Hydrochloride Solution •

  9. Slide 9: Our capabilities developed over years

    Our capabilities developed over years Research & Development Sustainability Ratings ◊ In house development of products ◊ ECOVADIS Sustainability platform – the company is ◊ DSIR approved R&D Facility rated very high with ‘Silver Badge’ ◊ R&D Lab approved by MS University of Baroda for ◊ One of those

  10. Slide 10: Our clients trust in our capabilities & chemistries

    Our clients trust in our capabilities & chemistries Company has built an excellent reputation globally – Testament to our Reliability and Trustworthiness Long-term supply agreement commenced from 1st January 2018 Contract 10 years Period Exclusive contract with a High performance product with dedica

  11. Slide 11: Our plants are multipurpose and multiproduct

    Our plants are multipurpose and multiproduct Ekalbara Located ~25 km away from the headquarter location at Vadodara, Gujarat. Dedicated multipurpose and multiproduct plants spread over 100 acres with total production capacity of • Strategically located in largest chemical 66,000 MT/P.A. manufacturin

  12. Slide 12: Our R & D facility is recognized by Government of India

    Our R & D facility is recognized by Government of India Research & Development Developed a comprehensive in-house R&D facility recognized by the Department of Science & Technology, Government of India, which is equipped with latest technology and equipment Every new and existing product undergoes a

  13. Slide 13: Our top management is committed to process safety

    Our top management is committed to process safety PHA Chemical Release • Process Hazard Analysis 01 • Dispersion Modeling Studies conducted for all products and • Storage Quantity Reduction processes 02 • Mechanical Integrity of Equipment Top Management 06 PSSR • Total commitment and • Pre-Startup s

  14. Slide 14: Our transportation is safe, systematic and sustainable

    Our transportation is safe, systematic and sustainable Logistics Safe, systematic and sustainable transportation is a key challenge to ever changing global chemical industry Pioneers in developing in-house ISO Tank station which is well equipped with state-of-the-art technology We manage over 600 IS

  15. Slide 15: Our products are delivered across the globe

    Our products are delivered across the globe One of the Pioneering Global Exporters from India since 1986 FY20 - Revenue Breakup Long term relations with Leading Global Chemical Giants 17% Sweden 83% Spain Germany Russia France Italy Switzerland Domestic International U.S.A. Japan China South Korea T

  16. Slide 16: Our board has vast industry experience

    Our board has vast industry experience Mr. Ashwin C. Shroff | Chairman Mr. Bernd Dill | Independent Director He is a science graduate, Mr. Shroff have emerged stronger, helping the growth of He is a German national, having emphasis on mathematics and natural sciences, Doctoral Industrial chemicals,

  17. Slide 17: Our company has adopted a sustainable method of doing business

    Our company has adopted a sustainable method of doing business Community Empowerment Biodiversity Serving the society in various areas Maintaining and enhancing green belt (flora and like health & hygiene, education, skill fauna) within the factory premises through development, vocational training e

  18. Slide 18: ESG at the heart of all we do

    ESG at the heart of all we do

  19. Slide 19: Corporate social responsibility

    Corporate social responsibility Women Empowerment Workshops Vocational Training Understanding the needs of communities, addressing them Our vision is to actively contribute towards through need-based projects and making them work together creating innovative and sustainable solutions in to help crea

  20. Slide 20: Awards and Recognitions – A glimpse

    Awards and Recognitions – A glimpse Government of Gujarat: FGI Award for Excellence in the field of Indian Chemical Council: Excellence in CSR Award Environment Pollution Abatement & Best in Social Responsibility Award Preservation Shri Atul Shroff MD & Union Leader Shri Ashok Shri Bimal V. Mehta, E

  21. Slide 21: Environment, health and safety

    Environment, health and safety Rainwater harvesting and recharging Green cover in Transpek premise Safety is our responsibility We have Full-fledged Effluent management system with a licensed discharge facility to the central Effluent channel Our company has 100 acres of land with a green belt of mo

  22. Slide 22: Socially responsible at the time of COVID-19

    Socially responsible at the time of COVID – 19 Activities done during COVID-19: Arranged for immunity boosting medicines including multi vitamins, zinc and iron sucrose injections, as per the requirements of Primary Health Centre – Mujpur, along with gloves and sanitizer bottles for their health sta

  23. Slide 23: Way Forward

    Way Forward

  24. Slide 24: Growth Initiatives

    Growth Initiatives Focus on Value-Added Products Growing opportunities in Pharma and Agro 01 One key focus area of the company is to introduce products that are intermediates (all current products are starting RMs) 04 We have identified few intermediates on which work is going on. Currently the prod

  25. Slide 25: Q2 FY21 - Financial Highlights

    Q2 FY21 - Financial Highlights

  26. Slide 26: Q2 FY21 – Consolidated Profit & Loss Account

    Q2 FY21 – Consolidated Profit & Loss Account Particulars (Rs. Crores) Q2 FY21 Q1 FY21 Q-o-Q Q2 FY20 Y-o-Y Revenue from Operations 77.3 74.7 125.3 Other Income 3.0 4.9 3.2 Total Revenue from operations 80.3 79.6 +1% 128.5 -38% Cost of materials consumed 41.7 32.7 61.3 Purchases of stock-in-trade 0.0

  27. Slide 27: Sep'20 - Consolidated Balance Sheet

    Sep’20 - Consolidated Balance Sheet Liabilities (Rs. Crores) Sep-20 Mar-20 Assets (Rs. Crores) Sep-20 Mar-20 Equity Non Current assets Equity Share capital 5.6 5.6 Property, Plant and Equipment 268.6 270.7 Other Equity 350.8 332.9 Capital work-in-progress 17.9 18.6 Right to use of lease assets 19.3

  28. Slide 28: Sep'20 - Consolidated Cash Flows Statement

    Sep’20 - Consolidated Cash Flows Statement Particulars (Rs. Crores) Sep-20 Sep-19 Net Profit Before Tax 4.1 23.1 Adjustments for: Non-Cash Items / Other Investment or Financial Items 15.5 16.6 Operating profit before working capital changes 19.6 39.7 Changes in working capital 26.6 20.1 Cash generat

  29. Slide 29: Analysis of Performance - Q2-FY21

    Analysis of Performance - Q2-FY21 ! The sales and margins are comparatively lower, largely due to change in product mix and impact of COVID-19 on end product application segments where Transpek’s products are used as raw materials. ! The Company does not expect a significant shift in long term deman

  30. Slide 30: Historical Financial Highlights

    Historical Financial Highlights

  31. Slide 31: Consolidated Profit & Loss Account

    Consolidated Profit & Loss Account Particulars (Rs. Crores) FY20 FY19 FY18 FY17 Revenue from Operations* 565.6 594.6 361.2 316.6 Other Income 17.4 17.8 9.8 7.4 Total Revenue 583.0 612.4 370.9 324.0 Cost of materials consumed 253.1 304.3 186.8 139.1 Purchases of stock-in-trade 0.0 0.1 8.0 6.7 Changes

  32. Slide 32: Consolidated Balance Sheet - Assets

    Consolidated Balance Sheet - Assets Assets (Rs. Crores) Mar-20 Mar-19 Mar-18 Mar-17 Non Current assets Property, Plant and Equipment 270.7 236.5 178.6 117.1 Capital work-in-progress 18.6 32.8 56.4 13.0 Right to use of lease assets 16.0 0.0 0.0 0.0 Investment In subsidiary 0.0 0.0 0.0 0.0 Financial A

  33. Slide 33: Consolidated Balance Sheet - Liabilities

    Consolidated Balance Sheet - Liabilities Liabilities (Rs. Crores) Mar-20 Mar-19 Mar-18 Mar-17 Equity Equity Share capital 5.6 5.6 5.6 5.6 Other Equity 332.9 305.8 241.4 200.0 Total Equity 338.5 311.4 246.9 205.6 Financial liabilities (i) Borrowings 44.6 68.8 85.4 25.0 (ii) Other Financial liabilitie

  34. Slide 34: Consolidated Financial Highlights

    Consolidated Financial Highlights Revenue* (Rs. In Cr) EBITDA* (Rs. In Cr) & EBITDA Margin (%) PAT (Rs. In Cr) & PAT Margin (%) 35 134.4 135.3 140 14 12.9% 100 +22% 11.1% 30 12 22.6% 23.9% 120 9.5% 612.4 25 10 73.0 80 583.0 19.0% 100 7.3% 65.7 20 15.7% 8 370.9 60 324.0 15 80 6 10 60.2 4 40 56.9 60 3

  35. Slide 35: Consistent Dividend Performance

    Consistent Dividend Performance Dividend Dividend Per Share 20.0 220 20 200% 200 18 180 16 160 14 140 125% 120 12 12.5 100 90% 90% 10 80 75% 9.0 9.0 8 60 50% 7.5 6 40 25% 5.0 4 20 2.5 0 2 FY14 FY15 FY16 FY17 FY18 FY19 FY20 34

  36. Slide 36: Thank You

    Contact Information Company : Investor Relations Advisor : Transpek Industry Limited Strategic Growth Advisors Pvt. Ltd. CIN: L23205GJ1965PLC001343 CIN: U74140MH2010PTC204285 Mr. Alak D. Vyas Mr. Shrikant Sangani / Mr. Abhishek Shah E: Shrikant.sangani@sgapl.net / abhishek.shah@sgapl.net E: secretar

Transpek Industry — Investor Presentation (November 2020) on 6ix